CNCCNC
US • —
$64.19
P/E
—
PEG
—
FCF Yield
—
Rev Growth YoY
+17.0% YoY
Gross Margin
7.2%
Health Score
5/10
D/E Ratio
0.87
Confidence
LOW
Business Snapshot
Centene Corporation operates as a diversified healthcare enterprise focused on government-sponsored healthcare programs, including Medicaid, Medicare, and the Health Insurance Marketplace. It generates the majority of its revenue from premiums received under managed care contracts with state governments and federal programs. As a major player in the managed care industry, Centene is one of the largest providers of Medicaid managed care services in the United States. The company's defining characteristic is its heavy reliance on government contracts, which provides a recurring revenue stream but also introduces significant regulatory and policy risk. With a market cap tier and TTM revenue unavailable in this data set, the full financial scale cannot be assessed here.
Financial Health
Gross margin stands at 7.2%, which is thin for the sector, though prior year data is not available for comparison. The net margin is negative at -3.2%, indicating the company is currently operating at a net loss...
Risk Assessment
- EARNINGS QUALITY — The company beat estimates in only 3 out of the last 4 quarters, which is a moderate track record but not a red flag.
- DEBT / LIQUIDITY — While the debt/equity ratio of 0.87x is not high, the current ratio of 1.1x is only slightly above 1.0x, indicating minimal cushion for covering short-term liabilities.
- TECHNICALS — RSI, MACD, and moving average data unavailable for this period; momentum cannot be independently confirmed.
- PROFITABILITY — Net margin of -3.2% and a return on equity of -28.7% indicate the company is currently unprofitable and destroying shareholder value.
- DATA COMPLETENESS — The absence of core metrics like P/E, revenue, and FCF creates a significant data vacuum that increases investment risk....
Gross margin stands at 7.2%, which is thin for the sector, though prior year data is not available for comparison. The net margin is negative at -3.2%, indicating the company is currently operating at a net loss. The balance sheet shows a debt-to-equity ratio of 0.87x and a current ratio of 1.1x, suggesting a manageable but not fortress-like level of leverage and adequate short-term liquidity. Return on equity is deeply negative at -28.7%, reflecting that the company is not generating a profit on its shareholders' equity. Free cash flow data is unavailable, making it impossible to assess the company's ability to generate cash for dividends, reinvestment, or debt reduction. Overall, the thin margins and negative profitability present significant financial health concerns for investors.
- EARNINGS QUALITY — The company beat estimates in only 3 out of the last 4 quarters, which is a moderate track record but not a red flag. - DEBT / LIQUIDITY — While the debt/equity ratio of 0.87x is not high, the current ratio of 1.1x is only slightly above 1.0x, indicating minimal cushion for covering short-term liabilities. - TECHNICALS — RSI, MACD, and moving average data unavailable for this period; momentum cannot be independently confirmed. - PROFITABILITY — Net margin of -3.2% and a return on equity of -28.7% indicate the company is currently unprofitable and destroying shareholder value. - DATA COMPLETENESS — The absence of core metrics like P/E, revenue, and FCF creates a significant data vacuum that increases investment risk.
Unlock the full AI report
Full 8-section analysis includes:
Metric deep-dives